19-52314196-C-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_144684.4(ZNF480):c.116C>A(p.Ala39Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000316 in 1,582,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_144684.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF480 | NM_144684.4 | c.116C>A | p.Ala39Glu | missense_variant | 3/5 | ENST00000595962.6 | NP_653285.2 | |
ZNF480 | NM_001297624.2 | c.116C>A | p.Ala39Glu | missense_variant | 3/4 | NP_001284553.1 | ||
ZNF480 | NM_001297625.2 | c.-32-1638C>A | intron_variant | NP_001284554.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF480 | ENST00000595962.6 | c.116C>A | p.Ala39Glu | missense_variant | 3/5 | 1 | NM_144684.4 | ENSP00000471754.1 | ||
ZNF480 | ENST00000468240.6 | n.116C>A | non_coding_transcript_exon_variant | 3/6 | 2 | ENSP00000417424.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151954Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250994Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135694
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1430222Hom.: 0 Cov.: 30 AF XY: 0.00000141 AC XY: 1AN XY: 711420
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151954Hom.: 0 Cov.: 29 AF XY: 0.0000135 AC XY: 1AN XY: 74210
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at